First clinical experience with Zr-89-Df-IAB22M2C PET/MRI in patients with metastatic cancer

被引：0
|
作者：
Schwenck, J. [1 ,2 ,3 ]
Sonanini, D. [2 ,4 ]
Seyfried, D. [2 ]
Ehrlichmann, W. [2 ]
Kienzle, G. [2 ]
Reischl, G. [2 ,3 ]
Wilson, I. [5 ]
Le, W. [5 ]
Smith, G. [5 ]
Korn, R. [5 ]
Seith, F. [6 ]
Forschner, A. [7 ]
Eigentler, T. [7 ]
Roecken, M. [3 ,7 ,8 ]
Zender, L. [3 ,4 ,8 ]
Pichler, B. [2 ,3 ,8 ]
Flatz, L. [7 ]
Kneilling, M. [2 ,3 ,7 ]
la Fougere, C. [1 ,3 ,8 ]
机构：
[1] Eberhard Karls Univ Tubingen, Dept Nucl Med & Clin Mol Imaging, Tubingen, Germany
[2] Eberhard Karls Univ Tubingen, Dept Preclin Imaging & Radiopharm, Werner Siemens Imaging Ctr, Tubingen, Germany
[3] Eberhard Karls Univ Tubingen, Cluster Excellence iFIT EXC 2180 Image Guided & F, Tubingen, Germany
[4] Eberhard Karls Univ Tubingen, Dept Med Oncol & Pneumol Internal Med 8, Tubingen, Germany
[5] ImaginAb Inc, Inglewood, CA USA
[6] Eberhard Karls Univ Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany
[7] Eberhard Karls Univ Tubingen, Dept Dermatol, Tubingen, Germany
[8] German Canc Res Ctr DKFZ Partner Site Tubingen, German Canc Consortium DKTK, Tubingen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-0863
引用
收藏
页码：S303 / S304
页数：2
相关论文
共 50 条
  • [1] [89Zr]Zr-Df-IAB22M2C in metastatic cancer
    Geraldes, Flavia Oliveira
    LANCET ONCOLOGY, 2021, 22 (12): : 1655 - 1655
  • [2] In vivo imaging of CD8+ T cells in metastatic cancer patients: first clinical experience with simultaneous [89Zr]Zr-Df-IAB22M2C PET/MRI
    Schwenck, Johannes
    Sonanini, Dominik
    Seyfried, Dominik
    Ehrlichmann, Walter
    Kienzle, Gabriele
    Reischl, Gerald
    Krezer, Pascal
    Wilson, Ian
    Korn, Ron
    Gonzalez-Menendez, Irene
    Quintanilla-Martinez, Leticia
    Seith, Ferdinand
    Forschner, Andrea
    Eigentler, Thomas
    Zender, Lars
    Roecken, Martin
    Pichler, Bernd J.
    Flatz, Lukas
    Kneilling, Manfred
    la Fougere, Christian
    THERANOSTICS, 2023, 13 (08): : 2408 - 2423
  • [3] 89Zr-df-IAB2M for PET/CT imaging of prostate cancer
    Batra, J. S.
    Jhanwar, Y. S.
    Vallabhajosula, S.
    Niaz, M. J.
    Flynn, T.
    Tagawa, S. T.
    Bander, N. H.
    Scherr, D. S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S295 - S295
  • [4] Optimization of 89Zr PET imaging using both phantom and clinical studies with [89Zr]-Df-IAB22M2C, an anti-CD8 minibody
    Daube-Witherspoon, Margaret
    Farwell, Michael
    Sunderland, John
    Viswanath, Varsha
    Korn, Ronald
    Wilson, Ian
    Karp, Joel
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [5] First in Human 89Zr-Df-IAB2M antiprostate specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer.
    Pandit-Taskar, Neeta
    O'Donoghue, Joseph
    Martinez, Danny
    Lyashchenko, Serge
    Carrasquillo, Jorge
    Durack, Jeremy
    Keppler, Jennifer
    Scher, Howard
    Larson, Steven
    Morris, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [6] CD8 Positron Emission Tomography (PET/CT) Imaging with 89Zr-Df-IAB22M2C in Patients with Inclusion Body Myositis
    Quinn, Colin
    Moulton, Kelsey
    Korn, Ron
    Le, William
    Goel, Niti
    Farwell, Michael
    Greenberg, Steven
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1427 - 1429
  • [7] Dose Reduction Strategies for Optimizing [89ZR]Zr-Df-IAB22M2C PET Scans Using Virtual Reconstruction (VR) Techniques
    Korn, R.
    Abbott, A.
    Sunderland, J.
    Wilson, I.
    Le, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S492 - S493
  • [8] First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake
    Pandit-Taskar, Neeta
    O'Donoghue, Joseph A.
    Ruan, Shutian
    Lyashchenko, Serge K.
    Carrasquillo, Jorge A.
    Heller, Glenn
    Martinez, Danny F.
    Cheal, Sarah M.
    Lewis, Jason S.
    Fleisher, Martin
    Keppler, Jennifer S.
    Reiter, Robert E.
    Wu, Anna M.
    Weber, Wolfgang A.
    Scher, Howard I.
    Larson, Steven M.
    Morris, Michael J.
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (12) : 1858 - 1864
  • [9] Pathologic correlation of 89Zr-Df-IAB2M antiprostate-specific membrane antigen (PSMA) minibody in patients with metastatic prostate cancer.
    Morris, Michael J.
    Solomon, Stephen Barnett
    Durack, Jeremy C.
    O'Donoghue, Joseph A.
    Lyashchenko, Serge K.
    Ruan Shutian
    Carrasquillo, Jorge A.
    Lewis, Jason Stuart
    Martinez, Danny F.
    Parada, Nicole A.
    Keppler, Jennifer
    Wu, Anna
    Reuter, Victor E.
    Weber, Wolfgang
    Scher, Howard I.
    Larson, Steven M.
    Pandit-Taskar, Neeta
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [10] Pilot study of the diagnostic utility of 89Zr-df-IAB2M and 68Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer
    Vlachostergios, Panagiotis J.
    Niaz, Muhammad J.
    Thomas, Charlene
    Christos, Paul J.
    Osborne, Joseph R.
    Margolis, Daniel J. A.
    Khani, Francesca
    Bander, Neil H.
    Scherr, Douglas S.
    Tagawa, Scott T.
    PROSTATE, 2022, 82 (04): : 483 - 492
12345